Follow
Ye Zhou
Ye Zhou
Shanghai Jiaotong University
No verified email
Title
Cited by
Cited by
Year
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
JK Dong, HM Lei, Q Liang, YB Tang, Y Zhou, Y Wang, S Zhang, WB Li, ...
Theranostics 8 (7), 1808, 2018
682018
A novel allosteric inhibitor of phosphoglycerate mutase 1 suppresses growth and metastasis of non-small-cell lung cancer
K Huang, Q Liang, Y Zhou, L Jiang, W Gu, M Luo, Y Tang, Y Wang, W Lu, ...
Cell metabolism 30 (6), 1107-1119. e8, 2019
642019
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma
MY Luo, Y Zhou, WM Gu, C Wang, NX Shen, JK Dong, HM Lei, YB Tang, ...
Cancer Research 82 (19), 3516-3531, 2022
202022
The system can't perform the operation now. Try again later.
Articles 1–3